QAM
Quantres Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $739K | Buy |
1,800
+600
| +50% | +$246K | 0.54% | 57 |
|
2018
Q4 | $448K | Sell |
1,200
-1,000
| -45% | -$373K | 0.28% | 122 |
|
2018
Q3 | $889K | Sell |
2,200
-1,600
| -42% | -$647K | 0.53% | 59 |
|
2018
Q2 | $1.31M | Buy |
3,800
+3,000
| +375% | +$1.04M | 0.76% | 39 |
|
2018
Q1 | $275K | Buy |
800
+100
| +14% | +$34.4K | 0.17% | 120 |
|
2017
Q4 | $263K | Sell |
700
-2,200
| -76% | -$827K | 0.17% | 172 |
|
2017
Q3 | $1.3M | Buy |
2,900
+1,800
| +164% | +$805K | 0.83% | 33 |
|
2017
Q2 | $540K | Sell |
1,100
-1,600
| -59% | -$785K | 0.35% | 95 |
|
2017
Q1 | $1.05M | Buy |
+2,700
| New | +$1.05M | 0.67% | 50 |
|
2016
Q4 | – | Sell |
-1,000
| Closed | -$402K | – | 226 |
|
2016
Q3 | $402K | Buy |
1,000
+400
| +67% | +$161K | 0.25% | 124 |
|
2016
Q2 | $210K | Buy |
+600
| New | +$210K | 0.13% | 160 |
|
2015
Q3 | – | Sell |
-3,700
| Closed | -$1.89M | – | 180 |
|
2015
Q2 | $1.89M | Sell |
3,700
-200
| -5% | -$102K | 1.49% | 14 |
|
2015
Q1 | $1.76M | Buy |
+3,900
| New | +$1.76M | 1.76% | 14 |
|
2014
Q3 | – | Sell |
-2,800
| Closed | -$791K | – | 207 |
|
2014
Q2 | $791K | Buy |
+2,800
| New | +$791K | 0.88% | 31 |
|